EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/19641174

J. Natl. Cancer Inst. 2009 Sep 2 101 17 1193-205

Download in:

View as

General Info

PMID
19641174